Bitcoin surged to $85,000 on September 21, 2026, its highest level in eight months, driven largely by a massive short squeeze that liquidated $648 million in bearish positions. This forced buying pushed prices higher, supported by strong inflows into US spot Bitcoin ETFs and a key technical milestone of closing above the 50-week moving average. The next price direction depends on whether institutional demand through ETFs continues and how long-term holders react, amid ongoing macroeconomic uncertainties like Federal Reserve policies. Analysts warn the $83,000 to $86,000 range is a sensitive zone that could amplify future moves either up or down.
Bitcoin surged to $85,000 on September 21, 2026, marking its highest level in eight months amid a $648 million short squeeze. For readers following the broader cryptocurrency market, here is Pluang's market snapshot as of Sep 21, 2026 17:21 WIB: out of 50 major cryptocurrencies tradable on Pluang, 45 rose and 4 fell today. Notable movers include ADA (Cardano) with a 1-day change of +9.48%, SNX (Synthetix) up +8.59%, and SUSHI (SushiSwap) gaining +8.41%.
Applied Materials projects sustained demand for its chipmaking equipment driven by AI infrastructure growth, expecting faster spending on wafer fab equipment through 2030. The company aims to increase its market share by over 2 percentage points from...
Gordon Haskett Capital Corporation set a $105 price target for Ollie's Bargain Outlet, suggesting an 18.1% upside from its current price around $89. The company’s board approved an additional $500 million share repurchase authorization, increasing to...
FRUIT Holdings, Inc. introduced PAVE, a new protocol designed to allow AI systems to call on human judgment and authority when needed. This approach ensures that human input retains its value, authority, and attribution within AI workflows, addressin...
AngioDynamics reported a 6.9% revenue increase to $80.9 million and a narrowed adjusted loss of 4 cents per share for Q1 fiscal 2027, with strong Med Tech sales growing 13.2%. Despite beating earnings expectations and improved gross margin, the stock...
Pomerantz LLP is investigating Cellebrite DI Ltd. for potential securities fraud following the company's Q2 2026 financial report, which showed Annual Recurring Revenue (ARR) below guidance and a lowered full-year ARR forecast. The company also abrup...
